facebook
TradedTraded
    Home
    Search
    Closings
    Listings
    On Market
    Off Market
    Add a listing
    Vaults
    shh
    Rankings
    News
    Data
    Socials
    More


Messages

Go Pro
+ Submit+ Submit a Deal
Home

/

Deals

/

California

/

Office

/

Lease

/

7000 Shoreline Court

Updated May 4, 2026

Amber Salzman Of CBRE Represents Epicrispr Biotechnologies In 24,780 Square Foot Lease Renewal In South San Francisco
LEASEDOffice

Amber Salzman Of CBRE Represents Epicrispr Biotechnologies In 24,780 Square Foot Lease Renewal In South San Francisco

7000 Shoreline Court

Building Size

24,780 SF

Asset Type

Office

Closing

Apr 23, 2026

About this deal

AI

The property asset is located at 7000 Shoreline Court in South San Francisco. This office space encompasses a total of 24,780 square feet. The market context highlights a slow recovery in the life sciences sector, which is relevant to the property's leasing activity. The location serves as the headquarters for Epicrispr Biotechnologies, which has renewed its lease at this site.

Summary of transaction details:

  • Property Type: Office
  • Transaction Amount: Not specified
  • Address: 7000 Shoreline Court
  • Market: South San Francisco
  • Asset Size: 24,780 SF
  • Tenant: Amber Salzman - Epicrispr Biotechnologies

The deal represents Amber Salzman as the tenant of Epicrispr Biotechnologies, indicating a continuation of their presence in the Bay Area. The renewal underscores tenant stability in the area despite the ongoing softness in the market, as reported by CBRE.

Players

Amber Salzman

Epicrispr Biotechnologies

Tenant

1 deal

Tenant

South San Francisco Office Market Snapshot

Boundary boundary · Office · Lease transactions

Loading comparables…

Deal FAQ

Visit Epicrispr Biotechnologies to view all their deals.

Purchase Price

Annual NOI

Loan Amount

Interest Rate (%)

Loan Term (yrs)

Down Payment (%)

Cap Rate

5.80%

Cash-on-Cash

-1.66%

Monthly Payment

$14,164

Annual Debt Svc

$169,964

Annual Cash Flow

$-11,334

DSCR

0.93

More Deals

Nearby Markets